VANCOUVER, Oct. 22, 2018 /PRNewswire/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has signed a Letter of Intent to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results